Table 3.
FBPP participants |
GENOA sub-sample |
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hypertension (after age 40) (n = 3093)b |
CHD (n = 4720)b |
Stroke (n = 4726)b |
Hypertension (after age 40) (n = 1288)b |
CHD (n = 1741)b |
Stroke (n = 1744)b |
|||||||||||||
HRc | 95% CI | P | HRd | 95% CI | P | HRd | 95% CI | P | HRe | 95% CI | P | HRf | 95% CI | P | HRb | 95% CI | P | |
Normotensive vs. nulliparous | 0.88 | 0.73–1.08 | 0.22 | 1.02 | 0.60–1.75 | 0.94 | 0.55 | 0.31–1.00 | 0.050 | 0.78 | 0.59–1.04 | 0.095 | 0.84 | 0.39–1.82 | 0.67 | 0.61 | 0.27–1.40 | 0.24 |
Hypertensive vs. normotensive | 1.53 | 1.25–1.87 | <0.001 | 1.14 | 0.78–1.68 | 0.50 | 1.86 | 1.16–2.98 | 0.010 | 1.88 | 1.49–2.39 | <0.001 | 0.65 | 0.32–1.30 | 0.22 | 2.10 | 1.19–3.71 | 0.010 |
CHD, coronary heart disease; CVD, cardiovascular disease.
Expressed as hazard ratios (HRs) with 95% confidence intervals (CIs) from Cox proportional hazards models fit using custom software to account for potential correlation among women within sibships.
Due to missing data, sample sizes are smaller than the total number of 4782 and 1754 women in the Family Blood Pressure Program (FBPP) and Genetic Epidemiology Network of Arteriopathy (GENOA) cohorts, respectively.
Model A adjusted for network, race, family history of CVD, smoking, BMI, education, and diabetes (time-dependent).
Model B adjusted for network, race, family history of CVD, smoking, BMI, education, diabetes mellitus (time-dependent), and hypertension (time-dependent).
Model C adjusted for race, family history of CVD, smoking, dyslipidemia, and diabetes (time-dependent).
Model D adjusted for race, family history of CVD, smoking, dyslipidemia, diabetes mellitus (time-dependent), and hypertension (time-dependent).